Henderson Jane - Insider Non-Derivative Transactions at Akero Therapeutics, Inc. (AKRO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 9, 2025, Henderson Jane's relationship to Akero Therapeutics, Inc. (AKRO) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKRO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Henderson Jane - Insider Non-Derivative Transactions of AKRO Common Stock

Henderson Jane - Insider Non-Derivative Transactions at AKRO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 10, 2025	Disposition -- (Common Stock)	9398	0	0
Aug 13, 2025	Sell -- (Common Stock)	3000	47.46	9398
Aug 13, 2025	M -- (Common Stock)	3000	7.01	12398
Jun 4, 2025	Acquisition -- (Common Stock)	9398	0	9398
Jun 17, 2023	Sell -- (Common Stock)	22498	54.46	0
Jun 17, 2023	Sell -- (Common Stock)	17502	53.79	22498
Jun 17, 2023	M -- (Common Stock)	40000	7.01	40000